EIT Health gives €6m to Covid-19 innovations

EIT Health has announced funds of over €6 million in the fight against Covid-19, which will be dedicated to 14 specially selected health innovation projects across Europe.

The projects will focus on immediate and impactful solutions that can be found to arm health services with better tools in navigating the pandemic.

As a Knowledge and Innovation Community of the European Institute of Innovation and Technology (EIT), the initiative from EIT Health actively contributes to the wider EU response to the crisis.

In its ‘Rapid Response’ initiative, EIT Health evaluated existing budget provisions for planned projects in 2020 and were able to reallocate funds to support promising solutions that may assist in the fight against Covid-19. The 14 projects selected cover biotechnology, diagnostics, digital health and medtech, and will be run by 36 partners. The projects will work directly with healthcare services as part of the consortia so that the solutions can be built in line with clinical needs and implemented without delay.

Jan-Philipp Beck, CEO, EIT Health, said: “We are proud of the fast and invaluable action taken by our employees, partners and wider network in response to the devastating Covid-19 pandemic. Covid-19 has highlighted our vulnerability but it also allows us the opportunity to come together and collaborate to find new ways of strengthening our health systems and create solutions to better equip the healthcare professionals working tirelessly to get us through this extremely difficult time. The projects that we have selected all show great potential using the power of the EIT Health network to develop cutting edge solutions.”

The projects, which will all be completed by the end of 2020, focus on:

Jorge Fernández García, director of innovation, EIT Health, said: “We thank each and every one of our partners who submitted to our Rapid Response, we received a high volume of creative and innovative proposals focussing on impactful solutions across many areas of pandemic response. The projects have been selected based on their scientific and technological innovation, and address areas of immediate and high unmet need in relation to COVID-19. All projects demonstrated that their implementation could and would be rapid with the support of EIT Health, and that they could be scaled across multiple geographies ensuring that access for many European citizens can be front of mind. Our network means that we are ideally placed to support the collaboration of industry, research, academia, and, crucially, health service delivery (such as large hospitals across Europe), to put solutions in the hands of those who need them.”

Back to topbutton